Breaking News: Medtronic Earnings, $30M Stolen and Genzyme (NYSE:MDT),(NASDAQ:GENZ)


Medtronic said it continues to expects first-quarter earnings of 79 cents a share to 81 cents a share. Wall Street analysts forecast earnings of 84 cents a share, according to a survey by FactSet Research.

Genzyme: Near Term Sell, Long Term Buy

Investing Ideas (4)

Genzyme Corporation (NASDAQ:GENZ) is trading at $48.81 in its 52-week range of $48 to $83, so where could the stock be going and what trades work in the short & long run?  Let's get into it.

Syndicate content

WallStNation.comThanks for visiting, to assist your investing research try using our Search (click to access) or review the list of Tickers (click to access) that link directly to articles related to the given stock/security.

To Browse our Most Recent Stories (click here)

Share Content

Share this article with others, is the Independent Wall Street Newspaper. Thanks for Reading!

Daily Market Summary

Please Review the Disclaimer and remember that information provided by our site is at the investor's sole financial risk. Please Review for more Details